Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary

Koji Goto1, Kentaro Nakai1, Satoshi Shizuta1

  • 1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Insights

Oral anticoagulation (OAC) was underused and suboptimal in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). This led to inadequate stroke prevention, highlighting a need for improved OAC management in real-world settings.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI) require careful management of antithrombotic therapy.
  • The combined use of oral anticoagulation (OAC) and dual antiplatelet therapy (DAPT) presents challenges in balancing efficacy and safety.
  • Real-world data on OAC use in AF patients post-PCI is limited.

Purpose of the Study:

  • To evaluate the real-world prevalence, intensity, safety, and efficacy of OAC in patients with AF undergoing PCI.
  • To assess the impact of OAC use and its intensity (Time in Therapeutic Range - TTR) on stroke incidence.
  • To examine the outcomes of continuing DAPT alongside OAC in this patient population.

Main Methods:

  • Retrospective analysis of the Coronary REvascularization Demonstrating Outcome Study in Kyoto registry cohort-2.
  • Inclusion of 1,057 patients with AF undergoing first PCI.
  • Comparison of stroke incidence between OAC and no-OAC groups, and analysis of TTR and its association with outcomes.

Main Results:

  • AF patients had a higher 5-year stroke incidence (12.8%) compared to non-AF patients (5.8%).
  • OAC was underused (47.9% of eligible patients) and intensity was suboptimal, with a mean TTR of 52.6%.
  • Adequate TTR (≥65%) was associated with significantly lower stroke incidence (6.9% vs 15.1%).

Conclusions:

  • OAC is underutilized and inadequately managed in real-world AF patients post-PCI, leading to insufficient stroke prevention.
  • Suboptimal OAC intensity (low TTR) is linked to increased stroke risk.
  • Continuing long-term DAPT with OAC did not demonstrate a reduction in stroke incidence in this cohort.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522